Palvella Therapeutics
Alexis Lawthers has been working in the healthcare industry since 2013. Alexis began their career as a Medical Front Desk Coordinator for Premier Orthopaedics and Sports Medicine in 2013. In 2015, they moved on to Chiltern as a Clinical Trial Associate. Alexis then joined Trevena, Inc. in 2016 as a Clinical Research Associate/CTA. In 2018, they began working as a Clinical Research Associate for American Regent, Inc. In 2019, they started working for Oyster Point Pharma as a Senior Clinical Research Associate and Clinical Research Associate. Most recently, in 2021, they joined Palvella Therapeutics as a Clinical Trial Manager.
Alexis Lawthers attended West Chester University of Pennsylvania from 2008 to 2012, where they earned a Bachelor of Science (B.S.) degree in Kinesiology and Exercise Science.
Palvella Therapeutics
Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.